Novorapid Flexpen (Insulin Aspart)

Insulin aspart, the active ingredient in Novorapid Flexpen, is a rapid-acting insulin analog presented as a solution for subcutaneous injection use. It controls blood glucose levels in people with diabetes mellitus. GNH USA supplies Novorapid Flexpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novorapid Flexpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novorapid Flexpen is a rapid‑acting insulin analog that lowers the blood glucose by target the post‑prandial glucose rise in diabetes management.

- Type 1 diabetes mellitus: Improves glycaemic control by replacing deficient insulin. - Diabetes Type 2 mellitus: Provides mealtime insulin to control post‑prandian glucose spikes. - Gestational diabetes: Assists in achieving tight glycemic the t t t t t t. -   -  

Common Side Effects: -  . -  . - hyp  . - …  .

t  

intro  t t place  t

  t  t